Physician

Bradley Saylors, M.D.

According to 2025 Medicare claims, Bradley Saylors, M.D. (NPI: 1609296698) practices dermatology in the Charleston-North Charleston, SC market, with the plurality of this provider's patient population coming from Berkeley, SC. This provider's primary affiliated billing organization is TRIDENT DERMATOLOGY, PA (NPI: 1366404659; TIN: 57-0821519) and primary practice location at 29406-9137.

Saylors' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,286 traditional Medicare patients, billed 5,615 HCPCS/CPT codes, and received $938,185 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 1,064 prescription claims across 438 beneficiaries totaling $384,405 in drug costs, led by Dupixent Pen (Dupilumab). Open Payments data shows 83 records totaling $1,747. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $87,148 to $938,185. Similarly, Part D prescription costs have risen steadily, from $72,472 to $384,405. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$469K$938K2018 Medicare payment: $87,148 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $165,875 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $185,264 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $323,160 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $509,494 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $631,195 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $938,185 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20184332,237$87,148
20198293,562$165,875
20204001,579$185,264
20215662,682$323,160
20221,0884,737$509,494
20231,2776,404$631,195
20241,2865,615$938,185

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$192K$384K2015 Drug cost: $72,472 (USD; Tot_Drug_Cst)2016 Drug cost: $67,049 (USD; Tot_Drug_Cst)2017 Drug cost: $47,179 (USD; Tot_Drug_Cst)2018 Drug cost: $225,185 (USD; Tot_Drug_Cst)2019 Drug cost: $231,421 (USD; Tot_Drug_Cst)2020 Drug cost: $70,351 (USD; Tot_Drug_Cst)2021 Drug cost: $178,006 (USD; Tot_Drug_Cst)2022 Drug cost: $267,361 (USD; Tot_Drug_Cst)2023 Drug cost: $287,697 (USD; Tot_Drug_Cst)2024 Drug cost: $384,405 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201527203$72,472
20162256$67,049
20172554$47,179
2018146308$225,185
2019301659$231,421
2020214373$70,351
2021286774$178,006
2022395909$267,361
20234731,140$287,697
20244381,064$384,405

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17311Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks567715$459
11102Biopsy of related skin growth, first growth204237$58
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more564635$48
17000Destruction of precancer skin growth, 1 growth368406$29
17003Destruction of precancer skin growth, 2-14 growths2671,200$4

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent PenDupilumab28854$122,992
FluorouracilFluorouracil521,512$3,489
Clobetasol PropionateClobetasol Propionate862,736$3,398
KetoconazoleKetoconazole1805,714$2,848
Triamcinolone AcetonideTriamcinolone Acetonide942,873$1,395

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.83$1,747Novartis Pharmaceuticals Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Bradley Saylors, M.D.?

Tedicare shows public-source Medicare data for Bradley Saylors, M.D. (NPI 1609296698), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Bradley Saylors, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Bradley Saylors, M.D.?

Bradley Saylors, M.D. is linked to TRIDENT DERMATOLOGY, PA (billing NPI 1366404659) in the available physician profile data.

Does Bradley Saylors, M.D. have Open Payments data?

Bradley Saylors, M.D. has 83 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.